Abundance of regulatory t cell (Treg) as a predictive biomarker for neoadjuvant chemotherapy in triple-negative breast cancer

Masanori Oshi, Mariko Asaoka, Yoshihisa Tokumaru, Fernando A. Angarita, Li Yan, Ryusei Matsuyama, Emese Zsiros, Takashi Ishikawa, Itaru Endo, Kazuaki Takabe

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Fingerprint

Dive into the research topics of 'Abundance of regulatory t cell (Treg) as a predictive biomarker for neoadjuvant chemotherapy in triple-negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences